Post-Marketing Safety Surveillance of a Childhood Pentavalent Diphtheria-Tetanus-Acellular Pertussis-Polio and Haemophilus influenzae Type B (DTaP-IPV//Hib) Vaccine in South Korea.

Yang, Kuhyun; Kim, Hyunjung; Ortiz, Esteban; Huoi, Catherine; Kang, Jinhan

Post-Marketing Safety Surveillance of a Childhood Pentavalent Diphtheria-Tetanus-Acellular Pertussis-Polio and Haemophilus influenzae Type B (DTaP-IPV//Hib) Vaccine in South Korea.

Yang, Kuhyun; Kim, Hyunjung; Ortiz, Esteban; Huoi, Catherine; Kang, Jinhan.

Afiliación

Yang K; Medical Affairs, Sanofi, Seoul, Republic of Korea.
Kim H; Medical Department, Sanofi, Seoul, Republic of Korea.
Ortiz E; Pharmacovigilance Department, Sanofi, Lyon, France.
Huoi C; Global Medical Affairs Department, Sanofi, Lyon, France.
Kang J; The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Republic of Korea. kjhan@catholic.ac.kr.

Infect Dis Ther ; 12(2): 499-511, 2023 Feb.

Article en En | MEDLINE | ID: mdl-36520326

Palabras clave

DTaP-IPV//Hib; Diphtheria; Haemophilus influenzae type b; Hib; PENTAXIM™; Pertussis; Polio; Post-marketing surveillance; Safety; Tetanus; Vaccines

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Screening_studies Idioma: En Revista: Infect Dis Ther Año: 2023 Tipo del documento: Article Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google